Surgery Partners, Inc. (SGRY) Misses Q2 EPS by 18c ; Offers Guidance

Surgery Partners, Inc. (NASDAQ: SGRY) reported Q2 EPS of ($0.12), $0.18 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $848.9 million versus the consensus estimate of $830.05 million.

2026 Guidance

Full year 2026 revenue guidance reaffirmed to be in the range of $3.35 billion to $3.45 billion vs consensus $3.41 billion.

For earnings history and earnings-related data on Surgery Partners, Inc. (SGRY) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Alto Neuroscience, Inc. (ANRO) Tops Q2 EPS by 10c
• Acrivon Therapeutics, Inc. (ACRV) Tops Q2 EPS by 21c